The Prognostic Significance of Tryptophanyl-tRNA Synthetase in Colorectal Cancer

被引:59
作者
Ghanipour, Arezo [1 ]
Jirstrom, Karin [4 ,5 ]
Ponten, Fredrik [2 ]
Glimelius, Bengt [3 ,6 ]
Pahlman, Lars [1 ]
Birgisson, Helgi [1 ]
机构
[1] Uppsala Univ, Dept Surg, Uppsala, Sweden
[2] Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, Uppsala, Sweden
[3] Uppsala Univ, Dept Oncol Radiol & Clin Immunol, Uppsala, Sweden
[4] Lund Univ, Malmo Univ Hosp, Dept Lab Med, Ctr Mol Pathol, Malmo, Sweden
[5] Lund Univ, CREATE Hlth Ctr Translat Canc Res, Lund, Sweden
[6] Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden
关键词
ENDOTHELIAL GROWTH-FACTOR; HUMAN PROTEIN ATLAS; TISSUE MICROARRAYS; FACTOR EXPRESSION; TUMOR-MARKERS; COLON-CANCER; VEGF-C; ANGIOGENESIS; FRAGMENT; THERAPY;
D O I
10.1158/1055-9965.EPI-09-0456
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Tryptophanyl-tRNA synthetase (TrpRS) is an aminoacyl-tRNA synthetase involved in protein synthesis and regulation of RNA transcription and translation and is an inhibitor of angiogenesis. TrpRS has been shown to be differentially expressed in colorectal cancer (CRC) and has thus been identified as a potential prognostic marker. The aim of this study was to analyze the correlation of TrpRS to the prognosis of patients diagnosed and treated for CRC within a defined population. Methods: With a polyclonal, monospecific IgG antibody, TrpRS expression was assessed by immunohistochemistry on tissue microarrays with tumors from a population-based CRC cohort (n = 320). Staining intensity and fraction of positive tumor cells were recorded. A Cox multivariate model including TrpRS expression, carcinoembryonic antigen, age, stage, tumor differentiation, and lymphatic and vascular vessel invasion was used to calculate the hazard ratio and 95% confidence interval (95% CI) for time to recurrence, disease-free survival, and overall survival. Results: Low expression of TrpRS correlated to increased risk for lymph node metastasis (P = 0.025) and a more advanced tumor stage (P = 0.001). Patients with tumors and increased levels of TrpRS expression had better survival than patients with low expression levels. Multivariate analyses revealed significantly better disease-free survival (relative risk, 0.59; 95% CI, 0.38-0.95) for patients with high expression than for patients with low expression of TrpRS. For colon cancer patients, a reduced risk for recurrence was seen in patients with increased TrpRS expression (relative risk, 0.23; 95% CI, 0.07-0.80). Conclusion: Low expression of TrpRS in tumor tissue correlates with increased risk for recurrence and worse survival in patients with CRC. This can be related to its antiangiogenic properties and could aid in the future selection of new drugs in the treatment of CRC. (Cancer Epidemiol Biomarkers Prev 2009;18(11):2949-56)
引用
收藏
页码:2949 / 2956
页数:8
相关论文
共 37 条
[1]  
Aboagye-Mathiesen G, 1999, ELECTROPHORESIS, V20, P344, DOI 10.1002/(SICI)1522-2683(19990201)20:2<344::AID-ELPS344>3.0.CO
[2]  
2-V
[3]   Intravitreal bevacizumab therapy for neovascular age-related macular degeneration:: a pilot study [J].
Abraham-Marin, Maura Lucy ;
Cortes-Luna, Carlos Fernando ;
Alvarez-Rivera, Griselda ;
Hernandez-Rojas, Myriam ;
Quiroz-Mercado, Hugo ;
Morales-Canton, Virgilio .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2007, 245 (05) :651-655
[4]   A web-based tool for in silico biomarker discovery based on tissue-specific protein profiles in normal and cancer tissues [J].
Bjorling, Erik ;
Lindskog, Cecilia ;
Oksvold, Per ;
Linne, Jerker ;
Kampf, Caroline ;
Hober, Sophia ;
Uhlen, Mathias ;
Ponten, Fredrik .
MOLECULAR & CELLULAR PROTEOMICS, 2008, 7 (05) :825-844
[5]  
Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979
[6]  
FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
[7]   ANTI-ANGIOGENESIS - NEW CONCEPT FOR THERAPY OF SOLID TUMORS [J].
FOLKMAN, J .
ANNALS OF SURGERY, 1972, 175 (03) :409-&
[8]   VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression [J].
George, ML ;
Tutton, MG ;
Janssen, F ;
Arnaout, A ;
Abulafi, AM ;
Eccles, SA ;
Swift, RI .
NEOPLASIA, 2001, 3 (05) :420-427
[9]   The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression [J].
Hanrahan, V ;
Currie, MJ ;
Gunningham, SP ;
Morrin, HR ;
Scott, PAE ;
Robinson, BA ;
Fox, SB .
JOURNAL OF PATHOLOGY, 2003, 200 (02) :183-194
[10]   Negative Serum Carcinoembryonic Antigen has Insufficient Accuracy for Excluding Recurrence from Patients with Dukes C Colorectal Cancer: Analysis with Likelihood Ratio and Posttest Probability in a Follow-Up Study [J].
Hara, Masayasu ;
Kanemitsu, Yukihide ;
Hirai, Takashi ;
Komori, Koji ;
Kato, Tomoyuki .
DISEASES OF THE COLON & RECTUM, 2008, 51 (11) :1675-1680